List Biological Laboratories

Executive Summary

List Biological Laboratories (List Labs) is a specialized CDMO and research reagent manufacturer with over 45 years of expertise in bacterial-derived products, including high-purity toxins, polysaccharides, and antibodies. The company has positioned itself as a key partner for the development and cGMP manufacturing of Live Biotherapeutic Products (LBPs) for microbiome applications, supporting innovators from early-stage process development through Phase I/II clinical supply. With a strong focus on quality and regulatory compliance, List Labs serves the infectious disease, vaccine, and antibody markets, leveraging its deep understanding of bacterial biology to provide custom manufacturing and research reagents. The company's long-standing reputation and niche capabilities make it a reliable partner for biotech and pharmaceutical firms seeking specialized bacterial product development.

Upcoming Catalysts (preview)

• TBDExpansion of LBP manufacturing capacity to meet growing microbiome demand60% success
• TBDNew strategic partnership with a major pharmaceutical company for bacterial toxin production50% success
• TBDFDA approval of a client's LBP product manufactured by List Labs30% success